White Paper


Covid and Sweden provide boost for Terveystalo

Terveystalo, one of Finland’s two for-profit healthcare giants, saw strong growth in 2021, helped by its recent move into Sweden and a Covid boost. We speak to Terveystalo’s head of investor relations and two analysts, to analyse growth drivers.

Synlab to IPO in Frankfurt

Europe's largest lab group Synlab will list on the Frankfurt Stock Exchange in Q2 after releasing an intention to float document on Wednesday morning. The group says revenue will grow 17% this year to €3bn+ revenue and that COVID-19 revenue will only continue to grow.

McDermott Will & Emery talks Europe’s complex regulatory landscape

Encroaching protectionism from governments across Europe is leading to some initiatives that might limit foreign investment in key strategic services like healthcare. Sharon Lamb, a partner with law firm MWE, talks to HBI about those new laws and a host of others introduced over the last year. It’s a complex regulatory and reimbursement landscape but MWE has a new report to help. 

Who is raising money?

Making sense of the money markets isn't easy right now. But some big players - Ramsay, Zur Rose and TPG are still raising money and some sectors such as German outpatient are still seeing M&A consolidation.

Introducing the HBI M&A Pipeline

You told us how important it is to your business to know when an asset is likely to sell, and when there is a deal to be done. This is why HBI is delighted to announce that after months of work behind the scenes our new M&A pipeline tool is live!

Verita pulls wraps off massive digital to retail preventative platform

Verita Health, the global preventative healthcare group aiming to reduce chronic disease and extend life expectancy, is building what it claims is the largest digital health platform in the world by buying and merging five platforms in Asia, Europe and the USA.  At the same time, Verita is moving its health offering into hotels, retail […]

Interview: Julia Khalimova, Healthcare Quality and Patient Safety Specialist, International Finance Corporation (IFC)

A recent study in the Lancet showed that it was more dangerous to have access to poor quality health care than to have no access to health care. That is particularly true in Emerging Markets where quality varies dramatically. Julia Khalimova, Healthcare Quality and Patient Safety Specialist at IFC, the arm of the World Bank that invests in the private sectors of emerging markets, has been studying the field for ten years and IFC has recently launched a tool to enable operators to measure and improve. We talk to her about the problem. What progress has been made? And what is the best solution?

Find Us